Search Results - Christina, Jr, Devisser

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS G12R -mutant pancreatic ductal adenocarcinoma

    Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS G12R -mutant pancreatic ductal adenocarcinoma by Kenney, Cara, Kunst, Tricia, Webb, Santhana, Christina, Jr, Devisser, Arrowood, Christy, Steinberg, Seth M, Mettu, Niharika B, Kim, Edward J, Rudloff, Udo

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: